Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Minoxidil improves blood flow in heart failure patients.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

PCOS may increase the risk of high blood pressure and heart issues.

Adrenal disorders often cause high blood pressure in young people.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

People with lichen planus are more likely to have abnormal blood fats than healthy people.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Doctors need to be better prepared to assess and treat obesity in patients.

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Hormonal therapies are safe and effective for treating adult women's acne.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Caregiver burden and patient health issues significantly affect emotional distress in both COPD patients and their caregivers.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.